Nuformix plc (LON:NFX)
London · Delayed Price · Currency is GBP · Price in GBX 0.1100
-0.0050 (-4.35%)
Oct 16, 2026, 4:14 PM GMT
Nuformix Market Cap
Nuformix has a market cap or net worth of 2.87 million as of October 16, 2026. It is the 45,845th most valuable company in the world and the 1,042nd biggest in the United Kingdom. Its market cap has decreased by 52.05% in one year.
Market Cap
2.87M
Enterprise Value
1.94M
Revenue
n/a
Global Rank
Country Rank
#1,042 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since October 16, 2017, Nuformix's market cap has decreased from 17.28M to 2.87M, a decrease of -83.39%. That is a compound annual growth rate of -18.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 2.87M | -46.64% |
| Dec 31, 2025 | 5.38M | 698.00% |
| Dec 31, 2024 | 674.17K | -72.13% |
| Dec 29, 2023 | 2.42M | 0.30% |
| Dec 30, 2022 | 2.41M | -63.56% |
| Dec 31, 2021 | 6.62M | -52.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genflow Biosciences | 10.20M |
| Fusion Antibodies | 7.57M |
| Solvonis Therapeutics | 7.15M |
| CRISM Therapeutics | 7.13M |
| OptiBiotix Health | 5.84M |
| Theracryf | 4.78M |
| Cizzle Biotechnology Holdings | 4.36M |
| Futura Medical | 3.11M |